» Articles » PMID: 30804774

Evaluation of Functional Decline in Alzheimer's Dementia Using 3D Deep Learning and Group ICA for Rs-fMRI Measurements

Overview
Specialty Geriatrics
Date 2019 Feb 27
PMID 30804774
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

: To perform automatic assessment of dementia severity using a deep learning framework applied to resting-state functional magnetic resonance imaging (rs-fMRI) data. : We divided 133 Alzheimer's disease (AD) patients with clinical dementia rating (CDR) scores from 0.5 to 3 into two groups based on dementia severity; the groups with very mild/mild (CDR: 0.5-1) and moderate to severe (CDR: 2-3) dementia consisted of 77 and 56 subjects, respectively. We used rs-fMRI to extract functional connectivity features, calculated using independent component analysis (ICA), and performed automated severity classification with three-dimensional convolutional neural networks (3D-CNNs) based on deep learning. : The mean balanced classification accuracy was 0.923 ± 0.042 ( < 0.001) with a specificity of 0.946 ± 0.019 and sensitivity of 0.896 ± 0.077. The rs-fMRI data indicated that the medial frontal, sensorimotor, executive control, dorsal attention, and visual related networks mainly correlated with dementia severity. : Our CDR-based novel classification using rs-fMRI is an acceptable objective severity indicator. In the absence of trained neuropsychologists, dementia severity can be objectively and accurately classified using a 3D-deep learning framework with rs-fMRI independent components.

Citing Articles

Deep learning and generative artificial intelligence in aging research and healthy longevity medicine.

Wilczok D Aging (Albany NY). 2025; 17(1):251-275.

PMID: 39836094 PMC: 11810058. DOI: 10.18632/aging.206190.


fMRI-based Alzheimer's disease detection via functional connectivity analysis: a systematic review.

Alarjani M, Almarri B PeerJ Comput Sci. 2024; 10:e2302.

PMID: 39650470 PMC: 11622848. DOI: 10.7717/peerj-cs.2302.


The effect of the apolipoprotein E ε4 allele and olfactory function on odor identification networks.

Frank C, Albertazzi A, Murphy C Brain Behav. 2024; 14(5):e3524.

PMID: 38702902 PMC: 11069025. DOI: 10.1002/brb3.3524.


Functional magnetic resonance imaging, deep learning, and Alzheimer's disease: A systematic review.

Warren S, Moustafa A J Neuroimaging. 2022; 33(1):5-18.

PMID: 36257926 PMC: 10092597. DOI: 10.1111/jon.13063.


Alzheimer disease stages identification based on correlation transfer function system using resting-state functional magnetic resonance imaging.

Mousa D, Zayed N, Yassine I PLoS One. 2022; 17(4):e0264710.

PMID: 35413053 PMC: 9004771. DOI: 10.1371/journal.pone.0264710.


References
1.
Rockwood K, Strang D, Macknight C, DOWNER R, Morris J . Interrater reliability of the Clinical Dementia Rating in a multicenter trial. J Am Geriatr Soc. 2000; 48(5):558-9. DOI: 10.1111/j.1532-5415.2000.tb05004.x. View

2.
Terry Jr A, Buccafusco J . The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. J Pharmacol Exp Ther. 2003; 306(3):821-7. DOI: 10.1124/jpet.102.041616. View

3.
Greicius M, Srivastava G, Reiss A, Menon V . Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci U S A. 2004; 101(13):4637-42. PMC: 384799. DOI: 10.1073/pnas.0308627101. View

4.
Smith S, Jenkinson M, Woolrich M, Beckmann C, Behrens T, Johansen-Berg H . Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage. 2004; 23 Suppl 1:S208-19. DOI: 10.1016/j.neuroimage.2004.07.051. View

5.
Schafer K, Tractenberg R, Sano M, Mackell J, Thomas R, Gamst A . Reliability of monitoring the clinical dementia rating in multicenter clinical trials. Alzheimer Dis Assoc Disord. 2004; 18(4):219-22. PMC: 4367865. View